6:31 PM
 | 
Jun 02, 2008
 |  BC Extra  |  Company News

FDA delays Sancuso PDUFA date again

ProStrakan (LSE:PSK) said FDA postponed the PDUFA date for an NDA for Sancuso because of resource constraints for a second time. A decision is...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >